| Human epistatic interaction controls IL7R splicing and increases multiple sclerosis risk G Galarza-Muñoz, FBS Briggs, I Evsyukova, G Schott-Lerner, ... Cell 169 (1), 72-84. e13, 2017 | 108 | 2017 |
| Antibody-dependent cellular cytotoxicity (ADCC)-mediating antibodies constrain neutralizing antibody escape pathway D Mielke, G Bandawe, J Pollara, MR Abrahams, T Nyanhete, PL Moore, ... Frontiers in immunology 10, 2875, 2019 | 24 | 2019 |
| HLA class II-restricted CD8+ T cells in HIV-1 virus controllers TE Nyanhete, AL Frisbee, T Bradley, WJ Faison, E Robins, T Payne, ... Scientific reports 9 (1), 10165, 2019 | 10 | 2019 |
| A MUC16 IgG binding activity selects for a restricted subset of IgG enriched for certain simian immunodeficiency virus epitope specificities JR Schneider, X Shen, C Orlandi, T Nyanhete, S Sawant, AM Carias, ... Journal of virology 94 (5), 10.1128/jvi. 01246-19, 2020 | 5 | 2020 |
| Polyclonal broadly neutralizing antibody activity characterized by Cd4 binding site and V3-glycan antibodies in a subset of hiv-1 virus controllers TE Nyanhete, RJ Edwards, CC LaBranche, K Mansouri, A Eaton, ... Frontiers in immunology 12, 670561, 2021 | 4 | 2021 |
| A tool for evaluating heterogeneity in avidity of polyclonal antibodies K Li, M Dodds, RL Spreng, M Abraha, RHC Huntwork, LC Dahora, ... Frontiers in Immunology 14, 1049673, 2023 | 1 | 2023 |
| CD8+ T cells: mechanistic target of rapamycin and eukaryotic initiation factor 2 in elite HIV-1 control T Nyanhete, GD Tomaras AIDS 32 (18), 2835-2838, 2018 | 1 | 2018 |
| Mechanisms of Immune Control in HIV-1 Virus Controllers TE Nyanhete Duke University, 2020 | | 2020 |
| A MUC16 IgG binding activity selects for a restricted subset of IgG enriched for certain SIV epitope specificities. JR Schneider, X Shen, C Orlandi, T Nyanhete, S Sawant, AM Carias, ... Journal of Virology, 2019 | | 2019 |
| Effector CD4+ T cells can convert to a CD8+, MHCII-restricted T cell lineage E Wong, T Nyanhete, A Frisbee, Q Ni, B Zhang, T Payne, S Liu, C Li, ... The Journal of Immunology 198 (1_Supplement), 74.3-74.3, 2017 | | 2017 |
